GenHealth.ai Secures $16.5 Million to Automate Medical Billing and Administration
Boston, Tuesday, 8 September 2026.
By deploying AI agents directly into existing systems, GenHealth.ai secured $16.5 million in Series A funding, helping healthcare providers boost revenues by over 30 percent.
Capital Injection and Strategic Focus
On Tuesday, September 8, 2026, healthcare artificial intelligence startup GenHealth.ai officially announced the closure of a $16.5 million Series A funding round [1][3]. The investment round was led by Flare Capital Partners, with participation from existing investors Craft Ventures and Obvious Ventures, alongside new investors Eniac Ventures, InHealth Ventures, Epsilon Health Investors, and ARTIS [3][4]. This venture capital influx is designated to expand the deployment of AI agents designed to automate administrative back-office operations for healthcare providers, including patient intake, eligibility verification, prior authorization, billing, and claim denials management [1][3].
Capital Injection and Strategic Focus
The latest funding brings GenHealth.ai’s total capital raised to $30 million, implying previous funding rounds totaled 13.5 million [1][4]. According to the company, these automated workflows help healthcare organizations recover revenue and increase payments by over 30 percent while integrating into existing provider software systems [1][3]. The AI agents operate within existing electronic health records (EHRs), payer portals, fax, and phone systems to complete workflows end-to-end alongside human teams [3][4].
The Administrative Landscape
This investment occurs against a backdrop of significant financial strain within the sector, as the US healthcare system spends approximately $1 trillion annually on administration [1][4]. GenHealth.ai founders Ricky Sahu and Ethan Siegel, who established the company in 2023, utilized a Large Medical Model trained on data from over 140 million patients to address these inefficiencies [1][3]. The core problem identified by leadership was not merely the AI technology itself, but the disconnection between AI and the systems providers already use, such as EHRs and bank accounts [3][4].
The Administrative Landscape
Competitive activity in the healthcare AI space remains high, with rival firm Parakeet Health announcing a major partnership with Qualderm, a national dermatology group, on September 7, 2026 [2]. Parakeet Health’s platform similarly targets patient access and appointment capacity using agentic AI, servicing six of the 10 largest dermatology groups [2]. This parallel development underscores a broader industry trend where provider organizations prioritize solutions that complete work within current systems rather than adding new systems of record [2][3].
Operational Metrics and Traction
GenHealth.ai executives report that company revenue has quadrupled in the last six months leading up to the announcement [3]. Furthermore, the company’s agents are on track to take more than 75 million actions inside customer systems over the next year [3]. These metrics suggest a rapid scaling of operational usage following the company’s expansion to over 20 employees since its seed round [1].
Operational Metrics and Traction
Early adopters are reporting substantial efficiency gains, with at-risk managed services company Guidehealth implementing GenHealth.ai’s solutions for intake and prior authorizations [3]. Sanjay Doddamani, CEO and founder of Guidehealth, stated that since implementation, they have seen a 4x productivity increase and are on track to save nearly $1.2 million annually [3]. Such outcomes align with GenHealth.ai’s claim that providers can get paid over 30 percent more, a result described as unheard of in revenue cycle management [1][4].
Future Expansion Plans
Looking ahead, GenHealth.ai is actively hiring for engineering, operations, and go-to-market roles to support expansion [1]. The company services medical groups, durable medical equipment suppliers, and health plans, operating with US-based staff for exception handling [1]. As the company scales, the focus remains on building infrastructure for AI agents to execute complex workflows reliably using context from their model trained on 140 million patients [3][4].